Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 13.46% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Industrials | 10.52% |
| 5 | Consumer Staples | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
McDonald's
MCD
$188B
| $836M | 1.95% |
8,293,900
-227,487
| -3% | -$23M |
|
|
NVO
2
Novo Nordisk
NVO
$218B
| $783M | 1.83% |
33,906,000
+1,746,400
| +5% | +$38.6M |
|
|
3
Colgate-Palmolive
CL
$72.4B
| $655M | 1.53% |
9,605,500
+2,259,100
| +31% | +$151M |
|
4
TSMC
TSM
$2.2T
| $564M | 1.31% |
26,354,151
+1,064,600
| +4% | +$21.9M |
|
|
LLTC
5
DELISTED
Linear Technology Corp
LLTC
| $552M | 1.29% |
11,732,400
+436,900
| +4% | +$20.2M |
|
6
Hershey
HSY
$34.8B
| $547M | 1.27% |
5,615,500
+1,116,826
| +25% | +$110M |
|
7
Intel
INTC
$530B
| $535M | 1.25% |
17,329,900
+3,322,200
| +24% | +$91M |
|
8
Apple
AAPL
$4.81T
| $518M | 1.21% |
22,293,732
-704,404
| -3% | -$15M |
|
9
GSK
GSK
$102B
| $474M | 1.11% |
7,095,520
+1,487,680
| +27% | +$101M |
|
10
Alaska Air
ALK
$5.07B
| $442M | 1.03% |
9,310,000
-68,602
| -0.7% | -$3.27M |
|
|
TWTC
11
DELISTED
TW TELECOM INC CL A COM
TWTC
| $371M | 0.86% |
9,196,800
+260,700
| +3% | +$8.6M |
|
12
Johnson & Johnson
JNJ
$599B
| $329M | 0.77% |
3,145,500
+486,300
| +18% | +$49.2M |
|
|
13
IBM
IBM
$198B
| $299M | 0.7% |
1,725,691
+1,513,447
| +713% | +$272M |
|
|
14
Pfizer
PFE
$142B
| $286M | 0.67% |
10,171,038
+9,692,268
| +2,024% | +$276M |
|
15
Domino's
DPZ
$10.9B
| $270M | 0.63% |
3,693,800
+461,200
| +14% | +$33.8M |
|
16
United Parcel Service
UPS
$96.2B
| $255M | 0.59% |
2,485,400
+722,862
| +41% | +$72.6M |
|
17
TJX Companies
TJX
$172B
| $231M | 0.54% |
8,676,400
+1,595,000
| +23% | +$45.5M |
|
18
NetEase
NTES
$82.9B
| $226M | 0.53% |
14,410,500
-444,000
| -3% | -$6.34M |
|
19
VeriSign
VRSN
$25.3B
| $224M | 0.52% |
4,581,076
-68,824
| -1% | -$3.43M |
|
20
Qualcomm
QCOM
$183B
| $221M | 0.52% |
2,796,300
-129,100
| -4% | -$10.3M |
|
21
Home Depot
HD
$332B
| $216M | 0.5% |
2,667,400
-1,245,900
| -32% | -$98.3M |
|
22
Mastercard
MA
$484B
| $216M | 0.5% |
2,934,300
+1,143,900
| +64% | +$85M |
|
|
23
Eli Lilly
LLY
$1.02T
| $208M | 0.48% |
3,342,000
-1,914,105
| -36% | -$114M |
|
24
Philip Morris
PM
$293B
| $190M | 0.44% |
2,256,600
-808,893
| -26% | -$69.6M |
|
25
Becton Dickinson
BDX
$42.6B
| $183M | 0.43% |
1,589,468
+213,918
| +16% | +$24.3M |
|
Similar funds
Renaissance Technologies's Q2 2014 Portfolio in Review
As of Q2 2014, Renaissance Technologies held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Renaissance Technologies added most to Pfizer in Q2 2014, an estimated $276M increase.
- Renaissance Technologies's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Renaissance Technologies fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Renaissance Technologies's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Renaissance Technologies opened 450 new positions and closed 492 in Q2 2014.
- Renaissance Technologies's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.